Analgesics in Slovakia

Analgesics in Slovakia
Diclofenac and naproxen are non-steroidal anti-inflammatory analgesics used to relieve mild pain. Both categories saw retail current value sales surge in 2022. Retail current value sales are set to continue to grow over 2023 in both categories, albeit at a slower rate. In retail volume terms, diclofenac witnessed a spike in 2022, with slower growth anticipated over 2023. Meanwhile, naproxen followed fast retail volume growth in 2021 with a moderate increase in 2022. Demand is set to drop in 2023...

Euromonitor International's Analgesics in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.